Author

Thompson A

January 30, 2017
Chronic hepatitis C burden and care cascade in Australia in the era of interferon-based treatment
Summary Background and aim Interferon-free direct-acting antiviral regimens for hepatitis C virus (HCV) infection have been recently available in Australia, beginning a new era in clinical and public health management of HCV infection. This study provided updated estimates of the HCV infection care cascade and burden in Australia as a reliable platform for assessing the […]

Read More
May 18, 2015
HCV-infected patients need access now to new direct-acting antiviral agents to avert liver- related deaths
Summary No abstract available. Countries: Australia Read the Full Report

Read More